Johnson & Johnson (JNJ) – Johnson & Johnson settle in New Hampshire

Johnson & Johnson (JNJ) – Johnson & Johnson settle in New Hampshire

Facebook
Twitter
LinkedIn

  • Reuters reported Johnson&Johnson JNJ would pay $40.5 million to settle New Hampshire’s 2018 claims over the US opioid epidemic and avert a trial scheduled to begin next week.
  • New Hampshire accused JNJ and its unit Janssen Pharmaceuticals of aggressively marketing opioids to doctors and patients and misrepresenting their addictive properties.
  • “This resolution represents a positive step forward to ensure these devastating business practices do not happen again,” Gov. Chris Sununu said in a statement.
  • New Hampshire will spend $31.5 million on the opioid fight after legal fees are paid, and Johnson & Johnson will be banned from selling or advertising opioids there.
  • In a statement, J&J admitted no wrongdoing and called its marketing and advertising of prescription opioids “appropriate and responsible.”
  • New Hampshire was one of the few states not to join Johnson & Johnson’s stake in a $26 billion statewide opioid deal in February in hopes of winning back more through lawsuits of its own.
  • J&J expects to be reimbursed $1.5 million from this settlement since New Hampshire did not participate.
  • Price promotion: JNJ shares are up 0.38% to $165.97 on the latest check Friday.
  • Photo by Arek Socha from Pixabay


Read full story here https://www.benzinga.com/general/biotech/22/09/28734021/johnson-johnson-to-settle-new-hampshire-opioid-lawsuit-with-payment-of-40-5m-report

More to explorer

Understanding Key Factors in Accidents

[ad_1] Pedestrian Safety Statistics Pedestrian safety is an urgent concern worldwide, with over 1.3 million people dying in traffic accidents annually. Pedestrians